Akpek Esen K, Bunya Vatinee Y, Saldanha Ian J
The Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD.
Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA.
Cornea. 2019 May;38(5):658-661. doi: 10.1097/ICO.0000000000001865.
Sjögren's syndrome (SS) is a common autoimmune disease affecting about four million Americans. Although approximately 1 in 10 patients with clinically-significant aqueous deficient dry eye has underlying SS, widespread underappreciation of SS leads to significant underdiagnosis, delays in diagnosis, and consequent morbidity and mortality. The purpose of this article is to illustrate that in addition to dry eye, SS can cause serious, vision-threatening extraglandular ocular manifestations.
We conducted a narrative review of studies that have examined the dry eye and extraglandular ocular complications of SS.
SS-related dry eye is a progressive condition with major negative impact on the quality-of-life of afflicted patients, not only due to symptoms of ocular discomfort but also visual dysfunction. In addition, SS can lead to corneal melt/perforation, uveitis, scleritis, retinal vasculitis, and optic neuritis. A major problem with currently-available SS disease activity measurement instruments is the lack of domains evaluating dry eye-related visual dysfunction. For example, one of the most commonly-used instruments for assessing patient symptoms in SS (the EULAR Sjögren's Syndrome Patient Reported Index [ESSPRI]) only includes one item (out of three) that addresses the severity of overall dryness, without mention of dry eye symptoms or vision-related quality-of-life. Similarly, no extraglandular ocular complications are included in currently-available SS disease activity instruments (e.g., the EULAR Sjögren's Syndrome Disease Activity Index [ESSDAI]).
There needs to be a paradigm shift in which eye care providers and rheumatologists become more familiar with various SS-related extraglandular ocular manifestations. Existing disease activity measurement instruments must incorporate dry eye symptoms, particularly those related to visual dysfunction. An evidence-based screening algorithm for determining which patients with dry eye should be tested for underlying SS may be particularly helpful in preventing delays in diagnosis.
干燥综合征(SS)是一种常见的自身免疫性疾病,约有400万美国人受其影响。尽管每10名临床上有明显泪液缺乏性干眼症的患者中约有1人患有潜在的SS,但对SS的普遍认识不足导致了严重的漏诊、诊断延迟以及随之而来的发病率和死亡率。本文的目的是说明,除干眼症外,SS还可引起严重的、威胁视力的眼外表现。
我们对研究SS干眼症和眼外并发症的研究进行了叙述性综述。
与SS相关的干眼症是一种进行性疾病,对患病患者的生活质量有重大负面影响,这不仅是由于眼部不适症状,还由于视觉功能障碍。此外,SS可导致角膜溶解/穿孔、葡萄膜炎、巩膜炎、视网膜血管炎和视神经炎。目前可用的SS疾病活动测量工具的一个主要问题是缺乏评估与干眼症相关的视觉功能障碍的领域。例如,用于评估SS患者症状的最常用工具之一(欧洲抗风湿病联盟干燥综合征患者报告指数[ESSPRI])仅包括三项中的一项,该项目涉及总体干燥的严重程度,未提及干眼症症状或与视力相关的生活质量。同样,目前可用的SS疾病活动工具(如欧洲抗风湿病联盟干燥综合征疾病活动指数[ESSDAI])中未包括眼外并发症。
需要进行范式转变,使眼科护理人员和风湿病学家更熟悉各种与SS相关的眼外表现。现有的疾病活动测量工具必须纳入干眼症症状,特别是那些与视觉功能障碍相关的症状。一种基于证据的筛查算法,用于确定哪些干眼症患者应接受潜在SS的检测,可能对预防诊断延迟特别有帮助。